| Year |
Citation |
Score |
| 2008 |
Jang C, Inder WJ, Obeyesekere VR, Alford FP. Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone Clinical Endocrinology. 69: 745-750. PMID 18363889 DOI: 10.1111/j.1365-2265.2008.03242.x |
0.337 |
|
| 2006 |
Christopher MJ, Rantzau C, Alford FP. The relationship between peripheral glucose utilisation and insulin sensitivity in the regulation of hepatic glucose production: studies in normal and alloxan-diabetic dogs. Diabetes/Metabolism Research and Reviews. 22: 155-67. PMID 16222656 DOI: 10.1002/dmrr.594 |
0.341 |
|
| 2005 |
McLachlan KA, Alford FP. The impact of acute elevation of non-esterified fatty acids on insulin sensitivity and secretion in women with former gestational diabetes Clinical Endocrinology. 62: 79-84. PMID 15638874 DOI: 10.1111/j.1365-2265.2004.02177.x |
0.331 |
|
| 2005 |
Beck-Nielsen H, Alford F, Hother-Nielsen O. Insulin Resistance in Glucose Disposal and Production in Man with Specific Reference to Metabolic Syndrome and Type 2 Diabetes Insulin Resistance: Insulin Action and Its Disturbances in Disease. 155-178. DOI: 10.1002/0470011327.ch6 |
0.308 |
|
| 2001 |
Levin K, Daa Schroeder H, Alford FP, Beck-Nielsen H. Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes Diabetologia. 44: 824-833. PMID 11508266 DOI: 10.1007/s001250100545 |
0.311 |
|
| 2001 |
Ward GM, Walters JM, Barton J, Alford FP, Boston RC. Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: A new approach to the insulin compartment Metabolism: Clinical and Experimental. 50: 512-519. PMID 11319711 DOI: 10.1053/Meta.2001.21029 |
0.358 |
|
| 2000 |
Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients Diabetes. 49: 1209-1218. PMID 10909980 |
0.313 |
|
| 1999 |
Kamarudin N, Hew FL, Christopher M, Alford J, Rantzau C, Ward G, Alford F. Insulin secretion in growth hormone-deficient adults: Effects of 24 months' therapy and five days' acute withdrawal of recombinant human growth hormone Metabolism: Clinical and Experimental. 48: 1387-1396. PMID 10582546 |
0.331 |
|
| 1999 |
Henriksen JE, Alford F, Vaag A, Handberg A, Beck-Nielsen H. Intracellular skeletal muscle glucose metabolism is differentially altered by dexamethasone treatment of normoglycemic relatives of type 2 diabetic patients Metabolism: Clinical and Experimental. 48: 1128-1135. PMID 10484052 DOI: 10.1016/S0026-0495(99)90126-9 |
0.359 |
|
| 1998 |
Christopher M, Hew FL, Oakley M, Rantzau C, Alford F. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy Journal of Clinical Endocrinology and Metabolism. 83: 1668-1681. PMID 9589675 DOI: 10.1210/jcem.83.5.4836 |
0.353 |
|
| 1997 |
Henriksen JE, Alford F, Ward GM, Beck-Nielsen H. Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients Diabetologia. 40: 1439-1448. PMID 9447952 DOI: 10.1007/s001250050847 |
0.339 |
|
| 1997 |
Hew L, Christopher M, Rantzau C, Oakley M, Ward G, Alford F. P-014. Growth hormone (GH) deficient adults remain insulin resistant after 24 months of GH therapy Endocrinology and Metabolism, Supplement. 4: 41. |
0.304 |
|
| 1996 |
Beck-Nielsen H, Henriksen JE, Alford F, Hother-Nielson O. In vivo glucose metalbolism, insulin secretion and, insulin action in europids with non-insulin-dependent diabetes mellitus (NIDDM) and their first-degree relatives Diabetic Medicine. 13. PMID 8894487 |
0.328 |
|
| 1996 |
Vaag A, Alford F, Beck-Nielsen H. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): Acquired versus genetic metabolic defects? Diabetic Medicine. 13: 806-815. PMID 8891456 DOI: 10.1002/(SICI)1096-9136(199609)13:9<806::AID-DIA179>3.0.CO;2-5 |
0.354 |
|
| 1996 |
Hew FL, Koschmann M, Christopher M, Rantzau C, Vaag A, Ward G, Beck-Nielsen H, Alford F. Insulin resistance in growth hormone-deficient adults: Defects in glucose utilization and glycogen synthase activity Journal of Clinical Endocrinology and Metabolism. 81: 555-564. PMID 8636267 DOI: 10.1210/jc.81.2.555 |
0.35 |
|
| 1996 |
Henriksen JE, Alford F, Handberg A, Vaag A, Beck-Nielsen H. Glucose processing during the intravenous glucose tolerance test Metabolism: Clinical and Experimental. 45: 598-605. PMID 8622603 DOI: 10.1016/S0026-0495(96)90030-X |
0.337 |
|
| 1995 |
Vaag A, Alford F, Henriksen FL, Christopher M, Beck-Nielsen H. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM Diabetologia. 38: 326-336. PMID 7758880 DOI: 10.1007/BF00400638 |
0.349 |
|
| 1995 |
McNair PD, Colman PG, Alford FP, Harrison LC. Reproducibility of the first-phase insulin response to intravenous glucose is not improved by retrograde cannulation and arterialization or the use of a lower glucose dose Diabetes Care. 18: 1168-1173. PMID 7587853 DOI: 10.2337/Diacare.18.8.1168 |
0.301 |
|
| 1995 |
Hew FL, Koschmann M, Krieger T, Christopher M, Rantzau C, Ward G, Alford F. Insulin tolerance test in patients with anterior pituitary hormone deficiency: Reduced insulin sensitivity Endocrinology and Metabolism. 2: 93-98. |
0.34 |
|
| 1994 |
Beck-Nielsen H, Hother-Nielsen O, Vaag A, Alford F. Pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment Diabetologia. 37: 217-221. PMID 8163059 DOI: 10.1007/s001250050097 |
0.323 |
|
| 1994 |
Henriksen JE, Alford F, Handberg A, Vaag A, Ward GM, Kalfas A, Beck- Nielsen H. Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism Journal of Clinical Investigation. 94: 1196-1204. PMID 8083360 |
0.388 |
|
| 1992 |
Walters JM, Ward GM, Kalfas A, Best JD, Alford FP. The effect of epinephrine on glucose-mediated and insulin-mediated glucose disposal in insulin-dependent diabetes Metabolism. 41: 671-677. PMID 1640854 DOI: 10.1016/0026-0495(92)90062-F |
0.39 |
|
| 1992 |
Colman PG, Stewart V, Kean J, Koschmann M, Alford F, Ward G, Deam D, Harrison LC. Comparison of two commonly used standard IVGTTs Diabetes Care. 15: 1053-1055. PMID 1505309 DOI: 10.2337/Diacare.15.8.1053 |
0.35 |
|
| 1992 |
Galvin P, Ward G, Walters J, Pestell R, Koschmann M, Vaag A, Martin I, Best JD, Alford F. A simple method for quantitation of insulin sensitivity and insulin release from an intravenous glucose tolerance test Diabetic Medicine. 9: 921-928. PMID 1478037 |
0.354 |
|
| 1992 |
Colman PG, Stewart V, Kean J, Koschmann M, Alford F, Ward G, Deam D, Harrison LC. Comparison of two commonly used standard IVCTTs Diabetes Care. 15. |
0.35 |
|
| 1992 |
Koschmann M, Alford FP, Ward GM, Walters J, Colman PG, Harrison LC. Reproducibility of estimating first phase insulin responses to intravenous glucose Diabetes, Nutrition and Metabolism - Clinical and Experimental. 5: 73-79. |
0.357 |
|
| 1991 |
Page R, Boolell M, Kalfas A, Sawyer S, Pestell R, Ward G, Alford F. Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in Cushing's disease: A minimal model analysis Clinical Endocrinology. 35: 509-517. PMID 1769133 |
0.357 |
|
| 1990 |
Best JD, Alford FP, Martin IK, Pestell RG, Ward GM. Practical application of methods for in vivo assessment of insulin secretion and action Hormone and Metabolic Research. 24: 60-66. PMID 2272628 |
0.34 |
|
| 1990 |
Sisions MJ, Alford FP, Marangou A, Ward G, Best J. Effect of prolonged hyperinsulinaemia on adipocyte insulin binding and action in normal man Diabetes Research and Clinical Practice. 10: 9-17. PMID 2249608 DOI: 10.1016/0168-8227(90)90076-6 |
0.357 |
|
| 1990 |
Pestell R, Alford F, Ramos R, Sawyer S, Best J, Ward G. Insulin secretion, insulin sensitivity and glucose-mediated glucose disposal in thyrotoxicosis: A minimal model analysis Clinical Endocrinology. 33: 481-493. PMID 2225490 DOI: 10.1111/J.1365-2265.1990.Tb03885.X |
0.341 |
|
| 1990 |
Ward GM, Walters JM, Aitken PM, Best JD, Alford FP. Effects of prolonged pulsatile hyperinsulinemia in humans. Enhancement of insulin sensitivity Diabetes. 39: 501-507. PMID 2180760 |
0.37 |
|
| 1989 |
Pestell RG, Crock PA, Ward GM, Alford FP, Best JD. Fenfluramine increases insulin action in patients with NIDDM Diabetes Care. 12: 252-258. PMID 2495916 |
0.372 |
|
| 1988 |
Crock PA, Ley CJ, Martin IK, Alford FP, Best JD. Hormonal and metabolic changes during hypothermic coronary artery bypass surgery in diabetic and non-diabetic subjects Diabetic Medicine. 5: 47-52. PMID 2964328 |
0.31 |
|
| 1987 |
Best JD, Ley CJ, Strauss BJG, Alford FP, Aitken PM. The clinical effects of mixing short- and intermediate-acting insulins in the treatment of non-insulin-dependent diabetes Medical Journal of Australia. 146: 621-627. PMID 3306298 |
0.371 |
|
| 1985 |
Nankervis A, Proietto J, Aitken P, Alford F. Hyperinsulinaemia and insulin insensitivity: studies in subjects with insulinoma Diabetologia. 28: 427-431. PMID 2995184 DOI: 10.1007/BF00280885 |
0.348 |
|
| 1984 |
Nankervis A, Proietto J, Aitken P, Alford F. Impaired insulin action in newly diagnosed type 1 (insulin-dependent) diabetes mellitus Diabetologia. 27: 497-503. PMID 6391994 DOI: 10.1007/BF00290383 |
0.399 |
|
| 1984 |
Proietto J, Nankervis A, Aitken P, Dudley FJ, Caruso G, Alford FP. Insulin resistance in cirrhosis: Evidence for a post-receptor defect Clinical Endocrinology. 21: 677-688. PMID 6391747 |
0.361 |
|
| 1984 |
Proietto J, Dudley FJ, Aitken P, Alford FP. Hyperinsulinaemia and insulin resistance of cirrhosis: The importance of insulin hypersecretion Clinical Endocrinology. 21: 657-665. PMID 6391746 |
0.375 |
|
| 1983 |
Harrad RH, Plumb AP, Prickett S, Alford FP, Sönksen PH. Intensive attention improves glycaemic control in insulin dependent diabetes without further advantage from home blood glucose monitoring British Medical Journal. 286: 59. PMID 6401470 |
0.312 |
|
| 1983 |
Proietto J, Nankervis A, Aitken P, Caruso G, Alford F. Glucose utilization in Type 1 (insulin-dependent) diabetes: Evidence for a defect not reversible by acute elevations of insulin Diabetologia. 25: 331-335. PMID 6357915 DOI: 10.1007/BF00253196 |
0.37 |
|
| 1983 |
Caruso G, Proietto J, Calenti A, Alford F. Insulin resistance in alloxan-diabetic dogs: Evidence for reversal following insulin therapy Diabetologia. 25: 273-279. PMID 6357913 DOI: 10.1007/BF00279943 |
0.391 |
|
| 1983 |
Proietto J, Nankervis A, Aitken P, Caruso G, Harewood M, Alford FP. The physiologic action of insulin on glucose uptake and its relevance to the interpretation of the metabolic clearance rate of glucose Metabolism. 32: 1022-1028. PMID 6353136 DOI: 10.1016/0026-0495(83)90071-9 |
0.374 |
|
| 1982 |
Proietto J, Harewood M, Aitken P, Nankervis A, Caruso G, Alford F. Validation of a practical in vivo insulin dose-response curve in man Metabolism. 31: 354-361. PMID 7043173 DOI: 10.1016/0026-0495(82)90110-X |
0.355 |
|
| 1982 |
Harewood MS, Proietto J, Dudley F, Alford FP. Insulin action and cirrhosis: Insulin binding and lipogenesis in isolated adipocytes Metabolism. 31: 1241-1246. PMID 6755167 DOI: 10.1016/0026-0495(82)90011-7 |
0.337 |
|
| 1982 |
Nankervis A, Proietto J, Aitken P, Harewood M, Alford F. Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in Type 2 (non-insulin-dependent) diabetes Diabetologia. 23: 320-325. PMID 6754516 DOI: 10.1007/BF00253737 |
0.396 |
|
| 1981 |
Prince RL, Larkins RG, Alford FP. The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects Metabolism. 30: 293-298. PMID 7010074 DOI: 10.1016/0026-0495(81)90155-4 |
0.319 |
|
| 1981 |
Nankervis A, Proietto J, Ng KW, Alford FP, Larkins R. The metabolic effects of chronic hyperglucagonaemia Clinical Endocrinology. 15: 325-333. PMID 6274544 |
0.328 |
|
| 1981 |
Alford F, Nankervis A, Proietto J, Aitken P. Hepatic and peripheral insulin sensitivity in diabetic subjects before and after insulin treatment Diabetologia. 21: 5. |
0.33 |
|
| 1980 |
Proietto J, Alford FP, Dudley FJ. The mechanism of the carbohydrate intolerance of cirrhosis Journal of Clinical Endocrinology and Metabolism. 51: 1030-1036. PMID 6999005 |
0.339 |
|
| 1979 |
Findlay DM, Omond S, Alford FP, Chisholm DJ. Hyperglycemia and glucagon suppression: possible importance of the vagus and enteric humoral factors Journal of Clinical Endocrinology and Metabolism. 48: 13-16. PMID 422694 |
0.305 |
|
| 1979 |
Alford FP, Chisholm DJ. Glucagon: New concepts about an 'old' hormone Australian and New Zealand Journal of Medicine. 9: 733-743. PMID 394738 |
0.319 |
|
| 1978 |
Zimmet P, Whitehouse S, Alford F, Chisholm D. The relationship of insulin response to a glucose stimulus over a wide range of glucose tolerance Diabetologia. 15: 23-27. PMID 680420 DOI: 10.1007/BF01219323 |
0.338 |
|
| 1978 |
Chisholm DJ, Alford FP, Harewood MS, Findlay DM, Gray BN. Nature and biologic activity of "extrapancreatic glucagon": Studies in pancreatectomized cats Metabolism. 27: 261-273. PMID 628351 DOI: 10.1016/0026-0495(78)90106-3 |
0.347 |
|
| 1978 |
Larkins RG, Martin FIR, Alford FP, Chisholm DJ. Relationship between α and β cell function before and after metabolic control in ketotic diabetic subjects Journal of Clinical Endocrinology and Metabolism. 46: 131-139. PMID 109454 |
0.328 |
|
| 1977 |
Warne GL, Alford FP, Chisholm DJ, Court J. Glucagon and diabetes. II. Complete suppression of glucagon by insulin in human daibetes Clinical Endocrinology. 6: 277-284. PMID 862206 |
0.339 |
|
| 1977 |
Perry-Keene DA, Alford FP, Chisholm DJ, Findlay DM, Larkins RG, Martin FI. Glucagon and diabetes. I. The failure of hyperglucagonaemia to influence the response of established diabetic ketoacidosis to therapy. Clinical Endocrinology. 6: 417-23. PMID 407039 |
0.328 |
|
| 1977 |
Zimmet P, Chisholm D, Alford F. The insulin response to oral glucose over a wide spectrum of glucose tolerance Proceedings of the Endocrine Society of Australia. 66. |
0.349 |
|
| 1975 |
Warne G, Court JM, Alford FP, Chisholm DJ. Glucagon suppression by insulin administration in human diabetes Proceedings of the Endocrine Society of Australia. 16. |
0.306 |
|
| 1971 |
Alford FP, Martin PIR, Pearson MJ. The significance and interpretation of mildly abnormal oral glucose tolerance Diabetologia. 7: 173-180. PMID 5560919 DOI: 10.1007/BF01212550 |
0.331 |
|
| Show low-probability matches. |